Swiss National Bank Sells 4,200 Shares of Select Medical Holdings Corporation $SEM

Swiss National Bank lessened its holdings in shares of Select Medical Holdings Corporation (NYSE:SEM) by 1.9% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 213,200 shares of the health services provider’s stock after selling 4,200 shares during the quarter. Swiss National Bank owned approximately 0.17% of Select Medical worth $3,560,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. GAMMA Investing LLC grew its stake in Select Medical by 217.4% in the first quarter. GAMMA Investing LLC now owns 6,501 shares of the health services provider’s stock worth $109,000 after purchasing an additional 4,453 shares during the period. Lazard Asset Management LLC grew its stake in Select Medical by 47.8% in the fourth quarter. Lazard Asset Management LLC now owns 6,974 shares of the health services provider’s stock worth $130,000 after purchasing an additional 2,255 shares during the period. Wealthquest Corp purchased a new stake in Select Medical in the first quarter worth $143,000. Quarry LP grew its stake in Select Medical by 963.0% in the fourth quarter. Quarry LP now owns 9,078 shares of the health services provider’s stock worth $171,000 after purchasing an additional 8,224 shares during the period. Finally, HBK Investments L P purchased a new stake in Select Medical in the fourth quarter worth $188,000. 89.48% of the stock is owned by hedge funds and other institutional investors.

Select Medical Trading Up 0.2%

NYSE SEM opened at $12.9160 on Thursday. Select Medical Holdings Corporation has a 12 month low of $11.65 and a 12 month high of $40.98. The stock has a market cap of $1.60 billion, a P/E ratio of 12.19, a P/E/G ratio of 0.68 and a beta of 1.25. The stock’s fifty day moving average price is $14.12 and its 200-day moving average price is $15.83. The company has a current ratio of 1.15, a quick ratio of 1.15 and a debt-to-equity ratio of 0.92.

Select Medical (NYSE:SEM) last released its earnings results on Thursday, July 31st. The health services provider reported $0.32 EPS for the quarter, topping analysts’ consensus estimates of $0.28 by $0.04. Select Medical had a return on equity of 8.87% and a net margin of 2.37%.The firm had revenue of $1.34 billion for the quarter, compared to analysts’ expectations of $1.35 billion. During the same period in the prior year, the firm posted $0.60 earnings per share. The company’s quarterly revenue was up 4.5% on a year-over-year basis. Select Medical has set its FY 2025 guidance at 1.090-1.19 EPS. As a group, equities analysts forecast that Select Medical Holdings Corporation will post 1.17 EPS for the current fiscal year.

Select Medical announced that its board has approved a stock repurchase plan on Thursday, May 1st that allows the company to buyback $1.00 billion in outstanding shares. This buyback authorization allows the health services provider to purchase up to 42.6% of its shares through open market purchases. Shares buyback plans are usually a sign that the company’s board of directors believes its stock is undervalued.

Select Medical Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, August 28th. Investors of record on Wednesday, August 13th will be given a dividend of $0.0625 per share. The ex-dividend date of this dividend is Wednesday, August 13th. This represents a $0.25 annualized dividend and a dividend yield of 1.9%. Select Medical’s dividend payout ratio (DPR) is 23.58%.

Wall Street Analyst Weigh In

SEM has been the topic of several recent research reports. Royal Bank Of Canada reduced their price target on Select Medical from $23.00 to $19.00 and set an “outperform” rating on the stock in a research note on Wednesday, May 7th. UBS Group reissued a “neutral” rating and issued a $14.00 target price (down from $15.00) on shares of Select Medical in a research note on Monday, August 4th. Three research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $20.25.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.